Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Comparison of Anti-Inflammatory Effects of Flavonoid-Rich Common and Tartary Buckwheat Sprout Extracts in Lipopolysaccharide-Stimulated RAW 264.7 and Peritoneal Macrophages.

Nam TG, Lim TG, Lee BH, Lim S, Kang H, Eom SH, Yoo M, Jang HW, Kim DO.

Oxid Med Cell Longev. 2017;2017:9658030. doi: 10.1155/2017/9658030. Epub 2017 Aug 27.

2.

Verteporfin Inhibits Cell Proliferation and Induces Apoptosis in Human Leukemia NB4 Cells without Light Activation.

Chen M, Zhong L, Yao SF, Zhao Y, Liu L, Li LW, Xu T, Gan LG, Xiao CL, Shan ZL, Liu BZ.

Int J Med Sci. 2017 Sep 3;14(10):1031-1039. doi: 10.7150/ijms.19682. eCollection 2017.

3.

The p38 pathway, a major pleiotropic cascade that transduces stress and metastatic signals in endothelial cells.

Corre I, Paris F, Huot J.

Oncotarget. 2017 May 29;8(33):55684-55714. doi: 10.18632/oncotarget.18264. eCollection 2017 Aug 15. Review.

4.

Verteporfin inhibits growth of human glioma in vitro without light activation.

Al-Moujahed A, Brodowska K, Stryjewski TP, Efstathiou NE, Vasilikos I, Cichy J, Miller JW, Gragoudas E, Vavvas DG.

Sci Rep. 2017 Aug 8;7(1):7602. doi: 10.1038/s41598-017-07632-8.

5.

The PERK arm of the unfolded protein response regulates satellite cell-mediated skeletal muscle regeneration.

Xiong G, Hindi SM, Mann AK, Gallot YS, Bohnert KR, Cavener DR, Whittemore SR, Kumar A.

Elife. 2017 Mar 23;6. pii: e22871. doi: 10.7554/eLife.22871.

6.

Cancer suppression by systemic inactivation of p38MAPK.

Brichkina A, Bulavin DV.

Oncotarget. 2017 Feb 28;8(9):14275-14276. doi: 10.18632/oncotarget.15293. No abstract available.

7.

Mapping out p38MAPK.

Bonney EA.

Am J Reprod Immunol. 2017 May;77(5). doi: 10.1111/aji.12652. Epub 2017 Feb 13. Review.

8.

A Tumor Cell-Selective Inhibitor of Mitogen-Activated Protein Kinase Phosphatases Sensitizes Breast Cancer Cells to Lymphokine-Activated Killer Cell Activity.

Kaltenmeier CT, Vollmer LL, Vernetti LA, Caprio L, Davis K, Korotchenko VN, Day BW, Tsang M, Hulkower KI, Lotze MT, Vogt A.

J Pharmacol Exp Ther. 2017 Apr;361(1):39-50. doi: 10.1124/jpet.116.239756. Epub 2017 Feb 2.

PMID:
28154014
9.

p38MAPK builds a hyaluronan cancer niche to drive lung tumorigenesis.

Brichkina A, Bertero T, Loh HM, Nguyen NT, Emelyanov A, Rigade S, Ilie M, Hofman P, Gaggioli C, Bulavin DV.

Genes Dev. 2016 Dec 1;30(23):2623-2636. doi: 10.1101/gad.290346.116.

10.

Murine Electrophysiological Models of Cardiac Arrhythmogenesis.

Huang CL.

Physiol Rev. 2017 Jan;97(1):283-409. Review.

11.

TLR and TNF-R1 activation of the MKK3/MKK6-p38α axis in macrophages is mediated by TPL-2 kinase.

Pattison MJ, Mitchell O, Flynn HR, Chen CS, Yang HT, Ben-Addi H, Boeing S, Snijders AP, Ley SC.

Biochem J. 2016 Sep 15;473(18):2845-61. doi: 10.1042/BCJ20160502. Epub 2016 Jul 11.

12.

Dual Inhibition of Rip2 and IRAK1/4 Regulates IL-1β and IL-6 in Sarcoidosis Alveolar Macrophages and Peripheral Blood Mononuclear Cells.

Talreja J, Talwar H, Ahmad N, Rastogi R, Samavati L.

J Immunol. 2016 Aug 15;197(4):1368-78. doi: 10.4049/jimmunol.1600258. Epub 2016 Jul 11.

13.

p38 MAPK Signaling in Osteoblast Differentiation.

Rodríguez-Carballo E, Gámez B, Ventura F.

Front Cell Dev Biol. 2016 May 6;4:40. doi: 10.3389/fcell.2016.00040. eCollection 2016. Review.

14.

Regulatory Roles of MAPK Phosphatases in Cancer.

Low HB, Zhang Y.

Immune Netw. 2016 Apr;16(2):85-98. doi: 10.4110/in.2016.16.2.85. Epub 2016 Apr 28. Review.

15.

p38 MAPK α and β isoforms differentially regulate plasma membrane localization of MRP2.

Schonhoff CM, Park SW, Webster CR, Anwer MS.

Am J Physiol Gastrointest Liver Physiol. 2016 Jun 1;310(11):G999-G1005. doi: 10.1152/ajpgi.00005.2016. Epub 2016 Mar 24.

16.

p38β Mitogen-Activated Protein Kinase Modulates Its Own Basal Activity by Autophosphorylation of the Activating Residue Thr180 and the Inhibitory Residues Thr241 and Ser261.

Beenstock J, Melamed D, Mooshayef N, Mordechay D, Garfinkel BP, Ahn NG, Admon A, Engelberg D.

Mol Cell Biol. 2016 May 2;36(10):1540-54. doi: 10.1128/MCB.01105-15. Print 2016 May 15.

17.

APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases.

Olabisi OA, Zhang JY, VerPlank L, Zahler N, DiBartolo S 3rd, Heneghan JF, Schlöndorff JS, Suh JH, Yan P, Alper SL, Friedman DJ, Pollak MR.

Proc Natl Acad Sci U S A. 2016 Jan 26;113(4):830-7. doi: 10.1073/pnas.1522913113. Epub 2015 Dec 23.

18.

Mitogen-activated protein kinase signaling pathway and invasion and metastasis of gastric cancer.

Yang M, Huang CZ.

World J Gastroenterol. 2015 Nov 7;21(41):11673-9. doi: 10.3748/wjg.v21.i41.11673. Review.

19.

Identification of circulating miRNAs profiles that distinguish malignant pleural mesothelioma from lung adenocarcinoma.

Gayosso-Gómez LV, Zárraga-Granados G, Paredes-Garcia P, Falfán-Valencia R, Vazquez-Manríquez ME, Martinez-Barrera LM, Castillo-Gonzalez P, Rumbo-Nava U, Guevara-Gutierrez R, Rivera-Bravo B, Ramirez-Venegas A, Sansores R, Negrete-Garcia MC, Ortiz-Quintero B.

EXCLI J. 2014 Jul 8;13:740-50. eCollection 2014.

20.

Stress kinases in the modulation of metabolism and energy balance.

Manieri E, Sabio G.

J Mol Endocrinol. 2015 Oct;55(2):R11-22. doi: 10.1530/JME-15-0146. Review.

Supplemental Content

Support Center